1IA
DRIO icon

1834 Investment Advisors’s DarioHealth DRIO Stock Holding History

1834 Investment Advisors’s Portfolio DRIO Stock Details DRIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-42
Closed -$11K – 481
2021
Q3 		$11K Hold
42
– – ﹤0.01% 389
2021
Q2 		$18K Hold
42
– – ﹤0.01% 372
2021
Q1 		$16K Buy
+42
New +$18.9K ﹤0.01% 349

Other funds holding DRIO

CHM
Collaborative Holdings Management New York $49.2M AUM 119.38% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
LC
L1 Capital Melbourne VIC 3000, Australia $2.55B AUM 80.12% 1-Year Est. Return
AWAM
Appian Way Asset Management New York $558M AUM 1.95% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

1834 Investment Advisors's DRIO Position: Q4 2021 in Review

1834 Investment Advisors sold out of DarioHealth (DRIO) in Q4 2021, closing a stake of 42 shares — an estimated $11K sold.

1834 Investment Advisors first reported a position in DRIO in Q1 2021 and held it in 3 quarters. The position peaked at $18K in Q2 2021. 60 funds tracked by Wall St. Rank hold DRIO as of Q4 2021.

  • 1834 Investment Advisors reported no remaining DarioHealth position as of Q4 2021 after selling out during the quarter.
  • 1834 Investment Advisors sold 42 DarioHealth shares in Q4 2021, an estimated $11K.
  • 1834 Investment Advisors first reported a position in DarioHealth in Q1 2021 and held it in 3 quarters.
  • 1834 Investment Advisors's DarioHealth position peaked at $18K in Q2 2021.
  • 60 funds tracked by Wall St. Rank held DarioHealth as of Q4 2021.

Based on 1834 Investment Advisors's 13F filing for Q4 2021, filed 16 Feb 2022.